Published in Eur J Pharmacol on April 14, 1987
Effects of acute and chronic clozapine on dopamine release and metabolism in the striatum and nucleus accumbens of conscious rats. Br J Pharmacol (1990) 0.90
Biochemical and behavioural properties of clozapine. Psychopharmacology (Berl) (1989) 0.86
Cerebral microdialysis combined with single-neuron and electroencephalographic recording in neurosurgical patients. Technical note. J Neurosurg (1999) 2.46
Catechol-O-methyl transferase: pharmacological aspects and physiological role. Pharmacol Rev (1975) 1.79
In vivo measurement of dopamine and its metabolites by intracerebral dialysis: changes after d-amphetamine. J Neurochem (1983) 1.60
Distinct opioid circuits determine the palatability and the desirability of rewarding events. Proc Natl Acad Sci U S A (2009) 1.51
Amphetamine and other weak bases act to promote reverse transport of dopamine in ventral midbrain neurons. J Neurochem (1993) 1.51
The contribution of tryptamine to the behavioural effects of l-Tryptophan in tranylcypromine-treated rats. Psychopharmacology (Berl) (1978) 1.45
Anxiogenic-like effects of chronic cannabidiol administration in rats. Psychopharmacology (Berl) (2011) 1.44
Antisense oligonucleotide-induced reduction in 5-hydroxytryptamine7 receptors in the rat hypothalamus without alteration in exploratory behaviour or neuroendocrine function. J Neurochem (1998) 1.43
Orphanin FQ/nociceptin blocks acquisition of morphine place preference. Brain Res (1999) 1.32
Intracerebroventricular orphanin FQ/nociceptin suppresses dopamine release in the nucleus accumbens of anaesthetized rats. Neuroscience (1996) 1.28
Overexpression of the Drosophila vesicular monoamine transporter increases motor activity and courtship but decreases the behavioral response to cocaine. Mol Psychiatry (2006) 1.24
Effects of p-chlorophenylalanine and alpha-methyltryptophan on behaviour and brain 5-hydroxyindoles. Neuropharmacology (1977) 1.24
Orphanin FQ/nociceptin modulation of mesolimbic dopamine transmission determined by microdialysis. J Neurochem (1999) 1.23
Influence of postweaning social isolation in the rat on brain development, conditioned behavior, and neurotransmission. Neurosci Behav Physiol (2003) 1.22
Concurrent release of ATP and substance P within guinea pig trigeminal ganglia in vivo. Brain Res (2001) 1.20
Differential effects of acute and chronic social defeat stress on hypothalamic-pituitary-adrenal axis function and hippocampal serotonin release in mice. J Neuroendocrinol (2006) 1.19
Effects of direct periaqueductal grey administration of a cannabinoid receptor agonist on nociceptive and aversive responses in rats. Neuropharmacology (2003) 1.17
Isolation rearing in rats: pre- and postsynaptic changes in striatal dopaminergic systems. Pharmacol Biochem Behav (1998) 1.15
Voltammetry in brain tissue: chronic recording of stimulated dopamine and 5-hydroxytryptamine release. Life Sci (1978) 1.15
Orphanin FQ/nociceptin attenuates motor stimulation and changes in nucleus accumbens extracellular dopamine induced by cocaine in rats. Psychopharmacology (Berl) (2001) 1.12
5-Hydroxytryptamine: the effects of impaired synthesis on its metabolism and release in rat. Br J Pharmacol (1978) 1.11
Cannabinoid receptors and reward in the rat: a conditioned place preference study. Psychopharmacology (Berl) (2000) 1.09
Resocialisation of isolation-reared rats does not alter their anxiogenic profile on the elevated X-maze model of anxiety. Physiol Behav (1991) 1.08
Determination of in vivo amino acid neurotransmitters by high-performance liquid chromatography with o-phthalaldehyde-sulphite derivatisation. J Neurosci Methods (1995) 1.08
Dopaminergic and serotonergic function following isolation rearing in rats: study of behavioural responses and postmortem and in vivo neurochemistry. Pharmacol Biochem Behav (1992) 1.07
Modification of 5-HT2 receptor mediated behaviour in the rat by oleamide and the role of cannabinoid receptors. Neuropharmacology (1999) 1.06
Isolation rearing induces recognition memory deficits accompanied by cytoskeletal alterations in rat hippocampus. Eur J Neurosci (2006) 1.05
Inflammation-induced changes in primary afferent-evoked release of substance P within trigeminal ganglia in vivo. Brain Res (2000) 1.05
Social isolation increases aggressive behaviour and alters the effects of diazepam in the rat social interaction test. Behav Brain Res (1996) 1.05
Studies on the behavioural effects of tryptophan and rho-chlorophenylalanine. Neuropharmacology (1976) 1.05
Naloxone fails to produce conditioned place aversion in mu-opioid receptor knock-out mice. Neuroscience (2001) 1.02
Excitability properties of medial forebrain bundle axons of A9 and A10 dopamine cells. Brain Res (1988) 1.02
Endogenous enkephalins, not endorphins, modulate basal hedonic state in mice. Eur J Neurosci (2005) 1.01
Comparison of seizure related amino acid release in human epileptic hippocampus versus a chronic, kainate rat model of hippocampal epilepsy. Epilepsy Res (1996) 1.01
Increased dopamine release in the human amygdala during performance of cognitive tasks. Nat Neurosci (2001) 1.00
A role for 5-ht6 receptors in retention of spatial learning in the Morris water maze. Neuropharmacology (2001) 0.99
Weak base model of amphetamine action. Ann N Y Acad Sci (1992) 0.99
Investigation of stretching behaviour induced by the selective 5-HT6 receptor antagonist, Ro 04-6790, in rats. Br J Pharmacol (1999) 0.98
Presynaptic versus postsynaptic localization of mu and delta opioid receptors in dorsal and ventral striatopallidal pathways. J Neurosci (1997) 0.98
Effects of coadministration of cannabinoids and morphine on nociceptive behaviour, brain monoamines and HPA axis activity in a rat model of persistent pain. Eur J Neurosci (2004) 0.97
5-HT6 receptor antagonists reverse delay-dependent deficits in novel object discrimination by enhancing consolidation--an effect sensitive to NMDA receptor antagonism. Neuropharmacology (2004) 0.97
A comparison of morphine-induced locomotor activity and mesolimbic dopamine release in C57BL6, 129Sv and DBA2 mice. J Neurochem (2001) 0.96
The involvement of 5-hydroxytryptamine and dopamine in the behavioural effects of alpha-methyltryptamine [proceedings]. Br J Pharmacol (1978) 0.96
Mu opioid receptor-effector coupling and trafficking in dorsal root ganglia neurons. Neuroscience (2006) 0.95
Effects of chronic modification of dietary fat and carbohydrate in rats. Biochem J (1981) 0.95
Pentylenetetrazol-induced kindling: early involvement of excitatory and inhibitory systems. Epilepsy Res (1996) 0.94
Increased sensitivity to amphetamine and reward-related stimuli following social isolation in rats: possible disruption of dopamine-dependent mechanisms of the nucleus accumbens. Psychopharmacology (Berl) (1990) 0.93
Involvement of 5-HT1A- and alpha 2-receptors in the decreased 5-hydroxytryptamine release and metabolism in rat suprachiasmatic nucleus after intravenous 8-hydroxy-2-(n-dipropylamino) tetralin. Br J Pharmacol (1986) 0.93
The role of tryptamine in the behavioural effects of tranylcypromine + L-tryptophan. Neuropharmacology (1979) 0.93
Behavioural rigidity and rule-learning deficits following isolation-rearing in the rat: neurochemical correlates. Behav Brain Res (1991) 0.93
Disruption of endogenous opioid activity during instrumental learning enhances habit acquisition. Neuroscience (2009) 0.93
Central c-fos expression following 20kHz/ultrasound induced defence behaviour in the rat. Brain Res Bull (1997) 0.92
Alterations in core body temperature, locomotor activity, and corticosterone following acute and repeated social defeat of male NMRI mice. Physiol Behav (2001) 0.92
Effect of established and putative anxiolytics on extracellular 5-HT and 5-HIAA in the ventral hippocampus of rats during behaviour on the elevated X-maze. Psychopharmacology (Berl) (1992) 0.92
Methodological considerations in rat brain BOLD contrast pharmacological MRI. Psychopharmacology (Berl) (2005) 0.91
A comparison of the locomotor effects induced by centrally injected TRH and TRH analogues. Regul Pept (1984) 0.91
Effects of MDMA exposure on the conditioned place preference produced by other drugs of abuse. Psychopharmacology (Berl) (2003) 0.91
Effect of chronic antidepressant treatment and subsequent withdrawal on [3H]-5-hydroxytryptamine and [3H]-spiperone binding in rat frontal cortex and serotonin receptor mediated behaviour. Psychopharmacology (Berl) (1983) 0.91
Functional magnetic resonance imaging studies of opioid receptor-mediated modulation of noxious-evoked BOLD contrast in rats. Psychopharmacology (Berl) (2005) 0.90
Effect of repeated methylphenidate administration on presynaptic dopamine and behaviour in young adult rats. J Psychopharmacol (2001) 0.90
Decreased GABA release following tonic-clonic seizures is associated with an increase in extracellular glutamate in rat hippocampus in vivo. Neuroscience (1995) 0.90
Feeding rats on diets rich in fat need not alter the concentrations of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in the brain. Biochem J (1982) 0.90
Effects of lesions and drugs on brain tryptamine. J Neurochem (1974) 0.89
Orphanin FQ/nociceptin attenuates the development of morphine tolerance in rats. Br J Pharmacol (2001) 0.89
Monitoring 5-hydroxytryptamine release in the brain of the freely moving unanaesthetized rat using in vivo voltammetry. Brain Res (1979) 0.89
Increased responsiveness to 5-methoxy-N,N-dimethyltryptamine in mice on a high tryptophan diet. Neuropharmacology (1979) 0.89
Changes in monoamine metabolites measured by simultaneous in vivo differential pulse voltammetry and intracerebral dialysis. Neuroscience (1984) 0.89
Neural-targeted gene therapy for rodent and primate hemiparkinsonism. Exp Neurol (1994) 0.89
Effects of 8-OHDPAT and 5-HT1A antagonists WAY100135 and WAY100635, on guinea-pig behaviour and dorsal raphe 5-HT neurone firing. Br J Pharmacol (1996) 0.89
The 5-HT1 receptor agonist RU-24969 decreases 5-hydroxytryptamine (5-HT) release and metabolism in the rat frontal cortex in vitro and in vivo. Br J Pharmacol (1985) 0.88
Enkephalin release promotes homeostatic increases in constitutively active mu opioid receptors during morphine withdrawal. Neuroscience (2007) 0.88
Blockade of ventral pallidal opioid receptors induces a conditioned place aversion and attenuates acquisition of cocaine place preference in the rat. Neuroscience (2003) 0.88
Long-term expression of a reporter gene from latent herpes simplex virus in the rat hippocampus. Brain Res Mol Brain Res (1995) 0.88
Functional coupling, desensitization and internalization of virally expressed mu opioid receptors in cultured dorsal root ganglion neurons from mu opioid receptor knockout mice. Neuroscience (2004) 0.88
In vivo neurochemical and behavioural effects of intracerebrally administered neurotensin and D-Trp11-neurotensin on mesolimbic and nigrostriatal dopaminergic function in the rat. Brain Res (1990) 0.87
Effect of isolation-rearing on conditioned dopamine release in vivo in the nucleus accumbens of the rat. J Neurochem (1998) 0.87
Chronic treatment with the α2-adrenoceptor antagonist fluparoxan prevents age-related deficits in spatial working memory in APP×PS1 transgenic mice without altering β-amyloid plaque load or astrocytosis. Neuropharmacology (2010) 0.87
Comparative studies of brain 5-hydroxytryptamine and tryptamine. Adv Biochem Psychopharmacol (1974) 0.87
Effects of central noradrenaline depletion by the selective neurotoxin DSP-4 on the behaviour of the isolated rat in the elevated plus maze and water maze. Psychopharmacology (Berl) (2001) 0.87
Analeptic effects of centrally injected TRH and analogues of TRH in the pentobarbitone-anaesthetized rat. Neuropharmacology (1984) 0.87
HSV-1-mediated NGF delivery delays nociceptive deficits in a genetic model of diabetic neuropathy. Exp Neurol (2006) 0.87
Measurement of extracellular basal levels of serotonin in vivo using nafion-coated carbon fibre electrodes combined with differential pulse voltammetry. Neuroscience (1988) 0.87
Central noradrenergic depletion by DSP-4 prevents stress-induced memory impairments in the object recognition task. Neuroscience (2009) 0.86
Location and release of TRH and 5-HT from amphibian skin. Cell Biol Int Rep (1981) 0.86
Differential cannabinoid-induced electrophysiological effects in rat ventral tegmentum. Neuropharmacology (2003) 0.86
Localization and release of 5-hydroxytryptamine thyrotrophin releasing hormone and substance P in rat ventral spinal cord. Comp Biochem Physiol C (1982) 0.86
The effects of monoamine neurotoxins on peptides in the rat spinal cord. Neuroscience (1982) 0.85
Involvement of 5-HT2 receptors in the behaviours produced by intrathecal administration of selected 5-HT agonists and the TRH analogue (CG 3509) to rats. Br J Pharmacol (1989) 0.85
Metabolism of a tryptophan load in the hypothalamus and other brain regions. J Neurochem (1975) 0.85
Lack of response suppression follows repeated ventral tegmental cannabinoid administration: an in vitro electrophysiological study. Neuroscience (2000) 0.85
Dopamine in nucleus accumbens: salience modulation in latent inhibition and overshadowing. J Psychopharmacol (2011) 0.85
Dopaminergic and glutamatergic interactions in the expression of self-injurious behavior. Dev Neurosci (1998) 0.85
Effects of the A 2A adenosine receptor antagonist KW6002 in the nucleus accumbens in vitro and in vivo. Pharmacol Biochem Behav (2006) 0.84
Conditioned dopamine release: dependence upon N-methyl-D-aspartate receptors. Neuroscience (1995) 0.84
Tolerance develops to the inhibitory effect of orphanin FQ on morphine-induced antinociception in the rat. Neuroreport (1999) 0.84
Repeated heroin administration increases extracellular opioid peptide-like immunoreactivity in the globus pallidus/ventral pallidum of freely moving rats. Psychopharmacology (Berl) (1998) 0.84
Inhibition of 5-hydroxytryptamine neuronal activity by the 5-HT agonist, DOI. Eur J Pharmacol (1991) 0.84
Isolation rearing in the rat disrupts the hippocampal response to stress. Neuroscience (2002) 0.84